SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-054172
Filing Date
2024-04-29
Accepted
2024-04-29 17:12:28
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm243000d2_defa14a.htm DEFA14A 19691
2 GRAPHIC tm243000d2_defa14aimg01.jpg GRAPHIC 447363
3 GRAPHIC tm243000d2_defa14aimg02.jpg GRAPHIC 321786
4 GRAPHIC tm243000d2_defa14aimg03.jpg GRAPHIC 429540
5 GRAPHIC tm243000d2_defa14aimg04.jpg GRAPHIC 296326
  Complete submission text file 0001104659-24-054172.txt   1989404
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 24892680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)